home
Bringing New Horizons to Therapy

 

General News

Ablatherm® HIFU is now available in more than 200 centers.

In September 2008, the 200th Ablatherm® HIFU treatment center started treating patients for localized prostate cancer.
In the year 2000, when Ablatherm® HIFU obtained CE marking and was cleared to treat patients in Europe, 4 centers were treating. Now, 8 years later, the opening of the 200th Ablatherm® HIFU treatment center confirms that Ablatherm® is gaining fast acceptance among urologists worldwide.
Print This Page